Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 97,249 | 131,121 | 355,643 | 172,568 | 186,727 |
| Marketable Securities | 321,664 | 337,600 | 208,354 | 150,067 | 154,890 |
| Receivables | 165,000 | N/A | 43 | 300,043 | 10,000 |
| TOTAL | $591,641 | $476,769 | $570,925 | $627,553 | $355,577 |
| Non-Current Assets | |||||
| PPE Net | 3,190 | 2,468 | 1,780 | 1,111 | 1,195 |
| Investments And Advances | 140,252 | 114,560 | 31,447 | 0 | 0 |
| Other Non-Current Assets | 9,642 | 10,060 | 10,477 | 612 | 1,179 |
| TOTAL | $153,084 | $127,088 | $43,704 | $1,723 | $2,374 |
| Total Assets | $744,725 | $603,857 | $614,629 | $629,276 | $357,951 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,615 | 3,049 | 3,629 | 3,510 | 775 |
| Accrued Expenses | 23,693 | 20,739 | 15,175 | 16,487 | 19,358 |
| TOTAL | $47,398 | $44,578 | $41,578 | $39,910 | $21,274 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 18,891 | 19,696 | 20,124 | 16,125 | N/A |
| Other Non-Current Liabilities | 10,356 | 10,855 | 10,971 | 0 | 0 |
| TOTAL | $22,032 | $27,364 | $31,727 | $28,922 | $N/A |
| Total Liabilities | $69,430 | $71,942 | $73,305 | $68,832 | $21,274 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,384 | 59,598 | 58,905 | 58,652 | 58,275 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -340,522 | -472,196 | -438,986 | -408,370 | -615,710 |
| Other shareholders' equity | -82 | 1,336 | -249 | -229 | -105 |
| TOTAL | $675,295 | $531,915 | $541,324 | $560,444 | $336,677 |
| Total Liabilities And Equity | $744,725 | $603,857 | $614,629 | $629,276 | $357,951 |